- Home
- SNDL vs HQL Comparison
SNDL vs HQL Comparison
Compare SNDL & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDL
- HQL
- Stock Information
- Founded
- SNDL 2006
- HQL 1992
- Country
- SNDL Canada
- HQL United States
- Employees
- SNDL N/A
- HQL N/A
- Industry
- SNDL Pharmaceuticals and Biotechnology
- HQL Investment Managers
- Sector
- SNDL Health Care
- HQL Finance
- Exchange
- SNDL Nasdaq
- HQL Nasdaq
- Market Cap
- SNDL 357.7M
- HQL 369.6M
- IPO Year
- SNDL 2019
- HQL N/A
- Fundamental
- Price
- SNDL $1.62
- HQL $13.37
- Analyst Decision
- SNDL Buy
- HQL
- Analyst Count
- SNDL 1
- HQL 0
- Target Price
- SNDL $3.25
- HQL N/A
- AVG Volume (30 Days)
- SNDL 2.3M
- HQL 120.9K
- Earning Date
- SNDL 07-31-2025
- HQL 01-01-0001
- Dividend Yield
- SNDL N/A
- HQL 11.56%
- EPS Growth
- SNDL N/A
- HQL N/A
- EPS
- SNDL N/A
- HQL 0.79
- Revenue
- SNDL $645,362,646.00
- HQL N/A
- Revenue This Year
- SNDL $4.70
- HQL N/A
- Revenue Next Year
- SNDL $3.87
- HQL N/A
- P/E Ratio
- SNDL N/A
- HQL $17.08
- Revenue Growth
- SNDL 1.30
- HQL N/A
- 52 Week Low
- SNDL $1.15
- HQL $11.34
- 52 Week High
- SNDL $2.40
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- SNDL 70.19
- HQL 54.99
- Support Level
- SNDL $1.36
- HQL $12.87
- Resistance Level
- SNDL $1.67
- HQL $13.50
- Average True Range (ATR)
- SNDL 0.09
- HQL 0.23
- MACD
- SNDL 0.03
- HQL -0.00
- Stochastic Oscillator
- SNDL 90.11
- HQL 51.52
About SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.